Blood Bank Guy Essentials Podcast

Blood shortages happen, but the one associated with COVID-19 is unique (and severe!). AABB Chief Medical Officer Dr. Claudia Cohn explains why and gives practical survival tips.

Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.

Plasma product names are confusing, but few are as misunderstood as Liquid Plasma. Dr. Chris Gresens explains why LP might be perfect for your transfusion service.

Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.

When most United States-based healthcare providers think of a hemoglobinopathy, sickle cell disease is the first to come to mind. That is understandable, given how frequently that disease is present in the US. However, worldwide, the various forms of thalassemia are a MASSIVE problem. Dr. Sujit Sheth takes us through the details around this deadly global disease, and how transfusion professionals can aid in care of thalassemia patients.

Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.

Usually, red cell alloantibodies are simple (find an antibody, give antigen-negative blood), but occasionally, some of them don't follow the rules! "Antibodies of variable clinical significance" act differently in different patients, sometimes causing hemolysis and sometimes not. They can be very hard to manage, especially because almost all blood donors are incompatible. The Monocyte Monolayer Assay, developed by today's guest, Sandy Nance, and her colleagues at the American Red Cross, helps answer the question, "Do we search the world for rare units of compatible blood, or can we just transfuse ABO-compatible red cells out of our regular inventory?" It's a great story, and this is a rare chance to hear about the MMA from one of the original sources, and to understand how to use it today.

Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.

Platelets have been used to save the lives of patients with low platelet counts for decades. For the most part, they are considered a safe and effective means to correct the problem of a patient not having enough platelets of their own. Despite that, we have wondered for decades about whether or not platelets should be given to patients with certain diseases where their platelets are being removed from circulation, like ITP, TTP, and HIT. My guest in this episode, Dr. Ruchika Goel, looked at platelet transfusion in those three entities, and she has data to share with us that might change the way you transfuse these patients.

In 2017, Dr. Mark Yazer appeared on this podcast to discuss the burgeoning interest in "Low-titer Group O Whole Blood (LTOWB)" for massive transfusions, particularly in trauma settings. Since then, more data and experience are available to guide the use of whole blood for trauma transfusion. Dr. Yazer updates us on the latest whole blood and incompatible plasma transfusion data, and clears up once and for all the "clear fluids" debate! Plus, there's some hockey trash talk...

Despite guidance in a 2015 publication from international experts in immunohematology and transfusion medicine, many clinicians and laboratorians have yet to integrate RHD genotyping into routine practice when a patient's RhD serologic typing is weaker than expected. In this interview, international immunohematology expert Sue Johnson shows us how we can do better!

Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.

Transfusion reactions that involve the heart and/or lungs, especially TACO and TRALI, are responsible for more transfusion deaths than any other entity. In this interview, Dr. Cserti-Gazdewich focuses on these two reactions and gives tips and strategies to identify, manage, and prevent them.

Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.

Warm autoantibodies have a well-deserved reputation as tough challenges, creating unfamiliar situations for both clinical and laboratory staff. I interviewed the authors of two recent papers that outlined best practices in this situation to gain some clarity and help!

Blood transfusion is less likely to transmit infections today than ever. Through a combination of screening questions, donor testing, and direct treatment of blood products, the vast majority of opportunities for transfusion-transmitted infections are eliminated. In this learner-focused interview, Dr. Suchi Pandey from Stanford outlines current strategies to keep blood safe.

Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.